GRAY SUSANNAH 4

What Happened

• Susannah Gray, a director of Maravai LifeSciences Holdings, Inc. (MRVI), was granted 46,293 restricted stock units (RSUs) on May 26, 2026. The reported grant price is $0.00, so there was no cash exchanged; the immediate reported value is $0.
• This is an award/grant (transaction code A), not a purchase or sale. RSUs represent a promise to deliver shares in the future if vesting conditions are met.

Key Details

• Transaction date: May 26, 2026; Filing date: May 28, 2026 (file appears timely under Form 4 rules).
• Shares/units granted: 46,293 RSUs; reported acquisition price: $0.00; immediate cash value shown: $0.
• Shares owned after the transaction: not disclosed in the provided filing.
• Footnote: These RSUs were awarded under the 2020 Omnibus Incentive Plan and vest in full upon the earlier of one year from grant or the date of the 2027 Maravai annual meeting of stockholders.

Context

• RSUs are time- or event-based equity awards (not an open-market purchase); they convert into shares only when they vest, so they do not represent immediately tradeable shares.
• Grants to directors are routine compensation and don't necessarily indicate a personal market view. They do, however, increase potential future insider ownership if and when they vest.